rxstat › Shortages › Insulin Isophane Human Biosynthetic Insulin Injection Human Biosynthetic
Insulin Isophane Human Biosynthetic Insulin Injection Human Biosynthetic shortage status
Discontinued
Reports by product
What's happening
One or more Insulin Isophane Human Biosynthetic Insulin Injection Human Biosynthetic products have been permanently discontinued by their manufacturers. If your product is affected, ask your pharmacist about equivalent products still on the market.
Insulin Isophane Human Biosynthetic Insulin Injection Human Biosynthetic is classified under “INSULINS AND ANALOGUES” (ATC A10AD).
Recent changes
- No changes recorded yet.
Common questions
When will Insulin Isophane Human Biosynthetic Insulin Injection Human Biosynthetic be back in stock in Canada?
Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.
Why is Insulin Isophane Human Biosynthetic Insulin Injection Human Biosynthetic in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Related drugs (insulins and analogues)
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.